Smithers Pharmaceutical Development Services to Attend the 22nd Annual PEGS Boston Conference
Smithers Pharmaceutical Development Services will attend the 22nd Annual PEGS Boston Conference from May 11–15, 2026, at the Omni Boston Hotel at the Seaport in Boston. The conference remains a leading event for professionals involved in antibody development, biologics, immunotherapy, cell therapy research, and protein engineering.
The event brings together biotechnology and pharmaceutical organizations focused on advancing biologic therapeutics and drug development programs. PEGS Boston 2026 will feature presentations and technical discussions across antibody engineering, immunogenicity, analytical characterization, protein expression, AI-driven biologics research, and emerging therapeutic modalities.
Supporting Biopharmaceutical Development Programs
Smithers Pharmaceutical Development Services provides bioanalytical testing, method development, and validation to support the development of large-molecule therapeutics from discovery through phase IV.
Participation at PEGS Boston reflects the continued focus of Smithers on supporting complex biologic and pharmaceutical development programs with scientific and regulatory expertise. The conference creates opportunities for technical discussions related to bioanalytical strategies.
Meet Agostinho G. Rocha, PhD, at PEGS Boston
Agostinho G. Rocha, Ph.D., Site Director of Smithers Pharmaceutical Development Services, will represent Smithers Pharmaceutical Development Services throughout the conference. Agostinho will be available to meet with attendees to discuss bioanalytical testing capabilities, pharmaceutical development support, and customized scientific solutions for biologic and pharmaceutical products.
Conference attendees involved in biologics development, antibody programs, protein therapeutics, and related pharmaceutical research are encouraged to connect with Agostinho during the event.
Industry Collaboration at PEGS Boston 2026
PEGS Boston continues to serve as a central meeting point for scientific collaboration across the biologics and pharmaceutical industries. The 2026 conference agenda includes topics covering antibody engineering, multispecific antibodies, immunotherapy, analytical methods, protein expression, and AI-enabled therapeutic development.
The conference environment supports direct engagement between pharmaceutical developers, CRO partners, technology providers, and scientific leaders working to advance therapeutic innovation and improve development efficiency.
Schedule a Meeting with Smithers Pharmaceutical Development Services
Smithers Pharmaceutical Development Services encourages PEGS Boston attendees to schedule a meeting with Agostinho G. Rocha, Ph.D., in advance of the conference. Early scheduling allows organizations to secure dedicated time to discuss development challenges, analytical requirements, and project objectives.